A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists surveyed believed that access to HIV prevention medications in pharmacies is important. Researchers examined attitudes, knowledge, and preferences around the provision of HIV prevention and other sexual and reproductive health services by pharmacists. The researchers also assessed the implementation of state policies that enable pharmacists to prescribe PrEP and PEP. Read and/or download an infographic summary about the HIV prevention results of this ... [Read More];
A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists surveyed believed that access to HIV prevention medications and contraception in pharmacies is important. Researchers examined attitudes, knowledge, and preferences around the provision of HIV prevention and other sexual and reproductive health services by pharmacists, including hormonal contraception and medication abortion. The researchers also assessed the implementation of state policies that enable pharmacists to prescribe PrEP, PEP, hormonal contraception, and emergency ... [Read More];
A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists surveyed believed that access to HIV prevention medications in pharmacies is important. Researchers examined attitudes, knowledge, and preferences around the provision of HIV prevention and other sexual and reproductive health services by pharmacists. The researchers also assessed the implementation of state policies that enable pharmacists to prescribe PrEP and PEP. Read and/or download a 2-page policy brief about the HIV prevention results ... [Read More];
A decade after the FDA approved PrEP for HIV prevention, PrEP is still not accessible to all Americans who might benefit from this HIV prevention strategy. In this policy brief, we describe opportunities for expanded PrEP access.
In the ongoing mpox (monkeypox) outbreak of 2022, California is the state with the highest number of cases and Los Angeles County (LAC) has the highest number of reported cases in the state. As of December 9, 2022, 2,245 confirmed mpox cases have been reported in LAC (LAC Department ofPublic Health, 2022). Most were among gay, bisexual, and other men who have sex with men (MSM). People living with HIV (PLWH) have been disproportionately impacted, with over 40% of diagnosed mpox cases being among PLWH.
Send this to a friend